NITROFURANTOIN CONTROLLED RELEASE DOSAGE FORM
The present invention generally relates to controlled release dosage forms which provide immediate release and sustained release of nitrofurantoin, and processes for their preparation. The controlled release dosage form includes a sustained release portion and an immediate release portion. The susta...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
13.05.2004
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention generally relates to controlled release dosage forms which provide immediate release and sustained release of nitrofurantoin, and processes for their preparation. The controlled release dosage form includes a sustained release portion and an immediate release portion. The sustained release portion includes nitrofurantoin and one or more pH dependent hydrophilic polymers. The immediate release portion includes nitrofurantoin.
L'invention concerne des formes galéniques à libération contrôlée permettant de libérer nitrofurantoïne de façon immédiate et prolongée, ainsi que des méthodes servant à les préparer. Cette forme galénique contient une partie de libération prolongée et une partie de libération immédiate. La partie de libération prolongée contient nitrofurantoïne et un ou plusieurs polymères hydrophiles dépendant du pH. La partie de libération immédiate contient nitrofurantoïne. |
---|---|
Bibliography: | Application Number: WO2003IB03517 |